CRL vs WSBK · rev $2.00B vs P/E 49, rev $42.7M
Charles River Laboratories (CRL) versus Winchester Bancorp, Inc. Common Stock (WSBK) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Winchester Bancorp, Inc. Common Stock (WSBK) is a banks - regional company listed on NASDAQ.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported WSBK revenue for 2025-06-30 was $42.7M. Net income was -$874.0K. Revenue was up 22.5% from 2024-06-30 to 2025-06-30. WSBK currently screens at market cap $114.3M and trailing P/E 49.1.
CRL currently screens at market cap $7.78B. WSBK currently screens at market cap $114.3M and trailing P/E 49.1.
Not investment advice. Open the CRL and WSBK stock pages for the full models.
Not investment advice.